Access to anti-retroviral drugs, male in Lebanon
Lebanon: Access to anti-retroviral drugs, male was 80.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, male in Lebanon, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, male in Lebanon stood at 80.0%.
Compared with earlier readings it is down 1.2% on the previous year and up 66.7% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Lebanon peaked at 90.0% in 2019 and was at its lowest, 3.0%, in 2000.
That places Lebanon 47th out of 141 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, male in Lebanon, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 3.0% | — |
| 2001 | 7.0% | +133.3% |
| 2002 | 11.0% | +57.1% |
| 2003 | 15.0% | +36.4% |
| 2004 | 19.0% | +26.7% |
| 2005 | 22.0% | +15.8% |
| 2006 | 23.0% | +4.5% |
| 2007 | 27.0% | +17.4% |
| 2008 | 30.0% | +11.1% |
| 2009 | 34.0% | +13.3% |
| 2010 | 39.0% | +14.7% |
| 2011 | 43.0% | +10.3% |
| 2012 | 46.0% | +7.0% |
| 2013 | 46.0% | +0.0% |
| 2014 | 48.0% | +4.3% |
| 2015 | 55.0% | +14.6% |
| 2016 | 63.0% | +14.5% |
| 2017 | 73.0% | +15.9% |
| 2018 | 79.0% | +8.2% |
| 2019 | 90.0% | +13.9% |
| 2020 | 87.0% | -3.3% |
| 2021 | 83.0% | -4.6% |
| 2022 | 81.0% | -2.4% |
| 2023 | 81.0% | +0.0% |
| 2024 | 80.0% | -1.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 19.1% | 3.0% | 34.0% | 10 |
| 2010s | 58.2% | 39.0% | 90.0% | 10 |
| 2020s | 82.4% | 80.0% | 87.0% | 5 |
Countries ranked near Lebanon
More gender data for Lebanon
- Child population (UN estimates and projections) 1,385 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -1.26 % change on previous year (2030)
- Population 4,719 (2030)
- Working-age population (UN estimates and projections) 4,719 (2030)
- Population (UN estimates and projections), annual growth rate 1.53 % change on previous year (2030)
- Age population, age 00, female, interpolated 44,373 (2025)
- Age population, age 00, male, interpolated 46,608 (2025)
- Age population, age 01, female, interpolated 44,213 (2025)
- Age population, age 01, male, interpolated 46,432 (2025)
- Age population, age 02, female, interpolated 44,307 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Lebanon?
- Access to anti-retroviral drugs, male in Lebanon was 80.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Lebanon?
- The highest recorded value was 90.0% in 2019.
- What is the lowest access to anti-retroviral drugs, male recorded in Lebanon?
- The lowest recorded value was 3.0% in 2000.
- How does Lebanon rank for access to anti-retroviral drugs, male?
- Lebanon ranks 47th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, male rising or falling in Lebanon?
- Over the last ten years it is up 66.7%. The long-run trend across the full record is volatile.
- Where does this Lebanon data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.